Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $2.21 Million - $3.06 Million
-30,434 Closed
0 $0
Q3 2021

Oct 12, 2021

BUY
$90.24 - $124.05 $403,011 - $554,007
4,466 Added 17.2%
30,434 $2.91 Million
Q2 2021

Jul 21, 2021

BUY
$93.66 - $139.27 $692,896 - $1.03 Million
7,398 Added 39.84%
25,968 $3.23 Million
Q1 2021

Apr 19, 2021

SELL
$116.57 - $155.01 $515,355 - $685,299
-4,421 Reduced 19.23%
18,570 $2.45 Million
Q4 2020

Feb 08, 2021

SELL
$99.61 - $142.12 $6,375 - $9,095
-64 Reduced 0.28%
22,991 $3.05 Million
Q3 2020

Nov 02, 2020

BUY
$72.92 - $102.01 $1.68 Million - $2.35 Million
23,055 New
23,055 $2.35 Million
Q2 2020

Aug 10, 2020

SELL
$55.75 - $92.75 $2.11 Million - $3.52 Million
-37,931 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$37.9 - $104.44 $374,186 - $1.03 Million
-9,873 Reduced 20.65%
37,931 $2.2 Million
Q4 2019

Feb 07, 2020

BUY
$77.66 - $99.74 $604,272 - $776,076
7,781 Added 19.44%
47,804 $4.42 Million
Q3 2019

Nov 06, 2019

SELL
$90.37 - $122.49 $691,511 - $937,293
-7,652 Reduced 16.05%
40,023 $3.62 Million
Q2 2019

Aug 06, 2019

SELL
$89.51 - $118.04 $216,972 - $286,128
-2,424 Reduced 4.84%
47,675 $5.63 Million
Q1 2019

May 08, 2019

BUY
$61.98 - $96.5 $49,584 - $77,200
800 Added 1.62%
50,099 $4.34 Million
Q4 2018

Feb 07, 2019

SELL
$56.04 - $82.66 $211,999 - $312,702
-3,783 Reduced 7.13%
49,299 $3.11 Million
Q3 2018

Nov 05, 2018

SELL
$48.29 - $80.6 $1.9 Million - $3.17 Million
-39,310 Reduced 42.55%
53,082 $4.19 Million
Q2 2018

Aug 02, 2018

SELL
$37.84 - $69.96 $980,774 - $1.81 Million
-25,919 Reduced 21.91%
92,392 $5.52 Million
Q1 2018

Apr 26, 2018

SELL
$39.82 - $57.53 $402,221 - $581,110
-10,101 Reduced 7.87%
118,311 $0
Q4 2017

Feb 01, 2018

BUY
$46.49 - $60.51 $5.7 Million - $7.42 Million
122,612 Added 2114.0%
128,412 $6.75 Million
Q4 2017

Jan 29, 2018

BUY
$46.49 - $60.51 $269,642 - $350,958
5,800
5,800 $6.44 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.6B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ifg Advisory, LLC Portfolio

Follow Ifg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.